Platelet H-3imipramine binding was measured in 17 children and adole
scents suffering from common (n = 10) and classical (n = 7) migraine a
nd 10 healthy control subjects. All patients had more than a 1-year hi
story of the disease and suffered at least one attack per month. All s
ubjects had been drug-free for at least 4 weeks prior to the study and
had never been treated with drugs active at the serotonergic system.
An increased density in H-3imipramine binding sites was detected in
the migraine patients (+ 51%; p < 0.05). The increase in maximal bindi
ng was more prominent in the classical migraine group (+ 63%) than in
the common migraine group (+ 43%). These results disagree with previou
s studies that reported decreased platelet imipramine binding in adult
migraine patients. The discrepancy may be related to chronicity of dr
ug treatment, long-term duration of disease and comorbidity of depress
ion and anxiety disorders in adult migrainous patients.